Embleema signs up a second pharma partner on its blockchain
In the press…
The revolution with blockchain in healthcare is reaching mainstream media : patients are getting access to tools that let them own data, and evidence from the real world is becoming the “source of truth” for pharma… Click to read about us in:
Real World Evidence is…
what allows us to prove the potential benefits or risks of a medical product. As per the FDA, it is derived from the analysis of data from electronic health records (EHRs), claims, product & disease registries and patient-generated data, including smart devices. It helps to test the safety & efficacy of drugs after the intial clinical trials themselves conducted in more controlled environments.
Thought of the day…
TL;DR…
- Embleema has signed its second official partnership with Servier Pharmaceuticals this december. A leading pharma with drugs for heart diseases, central nervous system ailments and oncology, it will take part in building Embleema’s decentralized Blockchain Network, hosting nodes to store and share data securely, and mining to guarantee the security of sensitive data.
- In Glascow , Robert Chu (CEO of Embleema) and Nicolas Schmidt participated in the Blockchain for Clinical Trials Forum invited by Maria Palombini from IEEE.
- With Jeanne Barnett, president of CysticFibrosis.com, they shared their experience on the joint pilot, validating how strongly patients support owning their data. Surveying 1200 patients and caregivers, it turns out 95% are willing to share data with research, and 68% if they are compensated.
- In Singapour, Alexis Normand attended the Blockshow conference to meet with blockchain investors, taking the temperature of local cryptomania.
- Vincent was in Monaco for the Blockchain Summit presenting Embleema. Next, he collected our prize for best positive impact startup at the Blockchain Agora!
Patient Testimony of the Month…
Listen to Alain-Michel Ceretti, President of France Assos Santé, the national association of patient advocacy groups in France, defending patient buy-in in the evaluation of care.
Coming up…
- Next week, Robert will present at the New York Health forum our latest traction building a consortium for healthcare.
- Alexis Normand and Nicolas Schmidt will be in San Francisco early january at the JP Morgan Healthcare Conference, discussing with industry leaders and investors about its plans to make 2019 the year of Blockchain for Healthcare as we move away from the cryptowinter of digital currencies, onto the spring of enterprise blockchain and patient data ownership…
